Managing COPD Learning Collaborative
|
|
- Mae Townsend
- 5 years ago
- Views:
Transcription
1 Managing COPD Learning Collaborative November 2-4, 2011 San Antonio, TX Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc. Geisinger Health System Carolyn C. Houk, MD FACP Paul Simonelli, MD, PhD 1
2 Team Composition Marlene Bannon Fred Bloom, M.D. Pamela Cook Jonathan Darer, M.D. Carolyn Houk, M.D. Mark Mossel Chris Seiler Paul Simonelli, M.D. Sanjay Udoshi, M.D. 2
3 COPD Project Goals Create system-wide registry for COPD Choose & implement best practice for COPD Develop continuum of care for COPD patients Address high-risk COPD patients 3
4 System-wide COPD Registry: Key Steps 1. Linkage of databases Identify patients who have provider-assigned diagnosis of COPD Link all PFT sites (>35) via common server Link EHR and PFT databases (CDIS) Identify all COPD patients who have had PFT's Fit GOLD criteria? Additional testing done? Generate site- and provider-specific lists of COPD without PFT's 4
5 Active Patients: Obstruction by Spirometry Measure # Pts % Pts Total active patients with Spirometry Total with FEV1/FVC < 70% % FEV1/FVC < 70%, COPD % FEV1/FVC < 70%, no COPD % 5
6 Difference in Age and Spirometry by Obstruction & COPD COPD FEV1/FVC < 0.70 Ave Age (years) Ave FVC (liters) Ave FEV1 (liters) FEV1/FVC (Ave) % < 40 years Number YES YES % 4.0% 2816 YES NO % 3.3% 1148 NO YES % 18.1% 3348 NO NO % 18.1%
7 COPD Registry: Key Steps 2. Pulmonary Function Testing Expansion of central PFT Lab capability "Outreach" PFT technician & testing (5 sites to date) Common protocols & standards Goal: 100% confirmation & stratification by PFT's 3. Education of Site-based Personnel In-lab training Webinars twice yearly CME courses 7
8 COPD Registry: Key Steps 4. Expansion of Registry Obstructive PFT's without a diagnosis of COPD Patient-based questionnaire* Site based administration (in pilot phase) Web-based (patient portal) Predictive modeling* Data warehouse-based comprehensive data * in development 8
9 Patient-Based Questionnaire 9
10 COPD: Best Practice 1. Align severity to GOLD criteria Internal EPIC-based diagnosis codes "Mild, Moderate, Severe, Very-severe" "severity to be determined Assign severity based on PFTs* * in development 10
11 Obstruction by Spirometry and COPD in PL: Difference by Diagnosis Description ICD9 # Pts % < 0.70 COPD Exacerbation % COPD w Emphysema % Asthma in COPD % COPD, Mild 496B 17 59% COPD, Moderate 496C 17 71% COPD, Severe 496D 20 90% COPD, Very Severe 496E 7 100% COPD, Severity to be Determined 496A % 11
12 COPD: Best Practice 2. Address other "phenotypes" of COPD* frequent exacerbation emphysema pulmonary hypertension chronic respiratory failure other co-morbidities * in development 12
13 COPD: Best Practice 3. Recommend therapy based on severity* Pharmacologic SABA for all LABA/ICS, LAMA for severe, exacerbator Consultation Pulmonary consults for Very Severe COPD * in development 13
14 COPD: Best Practice 4. Measure quality measures across population Smoking cessation Immunizations Appropriate Medications Advanced directives for severe COPD other? 14
15 COPD: Continuum of Care 1. Integration of sub-specialty care into the patientbased medical home On-going pilot projects: "Trigger" for sub-specialty management Management across the spectrum of disease Identify care teams Care Management 15
16 PCMH-Plus Care Team Model Patient with Severe COPD Primary Specialists Thoracic Medicine Primary Care Advanced Practitioner PCMH+ Primary Care Physician Care Manager Consultant Cardiology Advisor for COPD Population - Thoracic Medicine 16
17 COPD: Continuum of Care Ongoing Pilots: Improved physician & provider communication Ask a Doc chart review phone call video call (instant tele-medicine) New modes of patient management Telemedicine consultation 17
18 18
19 COPD: Continuum of Care 2. Refine treatment protocols* Leverage expertise of primary care, hospitalists, subspecialists, and population-based researchers On-going QI Outcomes research * in development 19
20 COPD: High-risk Patients 1. Re-admission for COPD exacerbation In-hospital co-management by Hospitalists and Pulmonologists Enhanced short-term clinic follow-up by PCP and Pulmonologists Enhanced management for Medical Home and Case Managers 20
21 COPD: Readmission Rate GMC Total Patients* Re-admit <30 days Re-admit <90 days COPD 1 o Dx (15.7%) 44 (28.8%) COPD any Dx (15.9%) 445 (24.0%) GWV COPD 1 o Dx (20.3%) 60 (32.1%) COPD any Dx (16.8%) 326 (26.5%) *Patient level data, Quality manager, 11/1/09 10/31/10 21
22 COPD: High-risk Patients 2. Advanced Lung Disease program Conduit for advanced therapy Transplant LVRS Research protocols Address co-morbid conditions Pulmonary Hypertension program 22
23 COPD: High-risk Patients 3. Regional identification of patients at risk* - "Beacon project" - Regional sharing of radiology data * in development 23
24 Lessons Learned Definition of COPD challenging by EHR analysis Smoking cessation program development difficult 24
25 Future Steps Finish what we started! 25
26 Questions? 26
Chronic Obstructive Learning Collaborative Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc..
Add your company logo here Chronic Obstructive Learning Collaborative Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc.. November 10-12 2010 Dallas, TX GEISINGER HEALTH SYSTEM INCORPORATING
More informationTACKLING COPD READMISSIONS. Wendy Presley RN
TACKLING COPD READMISSIONS Wendy Presley RN WHY START WITH COPD? HIGH VOLUME PROBLEM PRONE COSTLY And you just can t resist a challenge Chronic Obstructive Pulmonary Disease (COPD) is a preventable and
More informationChronic Obstructive Learning Collaborative Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc.
Chronic Obstructive Learning Collaborative Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc. November 2-4, 2011 San Antonio, Texas University of Michigan Faculty Group Practice Improving
More informationChronic Obstructive Learning Collaborative
Add your company logo here Chronic Obstructive Learning Collaborative Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc. July 24-26, 2013 Chicago, IL COPD Disease Management Program 1 2 3
More informationManaging Chronic Obstructive Pulmonary Disease (COPD) Learning Collaborative
Managing Chronic Obstructive Pulmonary Disease (COPD) Learning Collaborative 1 Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc. November 2-4, 2011 San Antonio, TX DuPage Medical Group COPD
More informationCARE OF THE ADULT COPD PATIENT
CARE OF THE ADULT COPD PATIENT Target Audience: The target audience for this clinical guideline is all MultiCare providers and staff including those associated with our Clinically Integrated Network. The
More informationReducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital
Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Dawn Waddell, PharmD, BCPS Clinical Pharmacy Manager Lisa Kingdon, PharmD, BCPS Clinical Pharmacy Specialist Dawn Waddell
More informationProject 3dii: Expansion of the Home Environmental Asthma Management Program
1 Project 3dii: Expansion of the Home Environmental Asthma Management Program Asthma Primary Care Project Participation Opportunity Purpose 2 This Project Participation Opportunity is specifically targeted
More informationCurrent Approaches to Asthma & COPD
10/11/18 Current Approaches to Asthma & COPD Lekshmi Santhosh, M.D. Assistant Professor, Pulm/Critical Care & Hosp Med Primary Care Medicine: Principles & Practice 10.11.2018 Revisiting the Dutch Hypothesis:
More informationBridges to Excellence Chronic Obstructive Pulmonary Disease Care Recognition Program Guide
Bridges to Excellence Chronic Obstructive Pulmonary Disease Care Recognition Program Guide Altarum Bridges to Excellence 3520 Green Court, Suite 300 Ann Arbor, MI 48105 bte@altarum.org www.bridgestoexcellence.org
More informationCOPD Update. Muhammad Talha Khan MD. COPD Exacerbations. COPD Clinical Importance. COPD Pathophysiology. Overview/Objectives
Overview/Objectives COPD Update Muhammad Talha Khan MD Pulmonologist St Croix Regional Medical Center, St Croix Falls, WI. Overview of COPD and disease impact Classification of COPD Severity Treatment
More informationUse of mobile health to improve patient adherence to the management of chronic obstructive pulmonary disease
Use of mobile health to improve patient adherence to the management of chronic obstructive pulmonary disease Hang DING,, Ian YANG, Derek IRELAND, Lisa MCCARTHY, Rekha HAKIM, Philip MASEL, Kirsten PHILLIPS,
More information#POMAD8 #ChoosePOMA #POMAD8 #ChoosePOMA #POMAD8 #ChoosePOMA
Where There s Smoke There s Obstruction Stephen G. Basheda, D.O., F.C.C.P. 1 Disclosures Dr. Basheda is an independent contractor for AstraZeneca Pharmaceuticals, LP and GlaxoSmithKline and on the speaker
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #52 (NQF 0102): Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL
More informationApproved Care Model for Project 3dii: Expansion of the Home Environmental Asthma Management Program
1 Approved Care Model for Project 3dii: Expansion of the Home Environmental Asthma Management Program OneCity Health Webinar January 6, 2016 Overview of presentation 2 Approach to care model development
More information2017 GOLD Report. Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017
2017 GOLD Report Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017 Lauren Munro; BSc(Pharm) Amanda Burns; BSc(Pharm) Pharmacy Residents The Moncton Hospital Objectives Explain
More information2017 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members
2017 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2017 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program
More informationMonthly Campaign Webinar. May 19, 2016
Monthly Campaign Webinar May 19, 2016 WEBINAR REMINDERS Webinar will be recorded today and available the week of May 23 rd Together2Goal.org Website (Improve Patient Outcomes Webinars) Email distribution
More informationCommissioning for Better Outcomes in COPD
Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationAnyone who smokes and/or has shortness of breath and sputum production could have COPD
COPD DIAGNOSIS AND MANAGEMENT CHECKLIST Anyone who smokes and/or has shortness of breath and sputum production could have COPD Confirm Diagnosis Presence and history of symptoms: Shortness of breath Cough
More informationRespiratory Therapists as COPD Educators
Respiratory Therapists as COPD Educators Becky Skinner, RRT-ACCS, CHT, MBA 38 th Annual Respiratory Care Seminar October 2018 1 Disclosure Statement I have no financial relationship with any manufacturer
More information2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members
2012 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2012 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program
More informationUSAID Health Care Improvement Project
IMPROVEMENT OBJECTIVE: Decrease asthma/copd morbidity and mortalityin affected adults and children through improved quality of asthma/copd case-management (ambulatory & hospital) Cross-cutting ambulatory
More informationSynergy Respiratory Care Dr. Lyle Melenka
1 2 Synergy Respiratory Care Dr. Lyle Melenka Respiratory Care 2 Accredited Pulmonary Function Labs Cardiac Care 2 Accredited Cardiac Exercise Stress Testing labs WoW Wellness of Workers Early Identification
More informationChronic Obstructive Pulmonary Disease (COPD).
Chronic Obstructive Pulmonary Disease (COPD). Linde: Living healthcare 02 03 Chronic Obstructive Pulmonary Disease (COPD). A pocket guide for healthcare professionals. COPD the facts Moderate to severe
More informationASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?
ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,
More informationOPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING 10/16/2018 DISCLOSURES I have no financial or other disclosures
OPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING J. Michael Fuller, MD, MEd, FACP, FCCP Associate Professor of Medicine University of South Carolina Greenville DISCLOSURES I have no financial or other
More informationUsing Pay-for-Performance to Improve COPD Care MHC64474 SV64474
Using Pay-for-Performance to Improve COPD Care MHC64474 SV64474 1 Session Objectives Discuss Chronic Obstructive Pulmonary Disease (COPD), its impact and opportunities for improved care Review Pay for
More informationMULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient
Clinical Guideline Ver. 2.0 MULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient Target Audience: The target audience for this clinical guideline is all MHS providers
More informationImproving Asthma and. Management with Spirometry 360
Improving Asthma and COPD Diagnosis and Management with Spirometry 360 CIN Webinar March 28, 2012 1 University of Washington Spirometry 360 Team Jim Stout, MD, MPH Principal Investigator t Dennis Burges
More informationData-Driven Study Feasibility Assessment and Impact on Successful Execution of Clinical Trial Protocols
Data-Driven Study Feasibility Assessment and Impact on Successful Execution of Clinical Trial Protocols Bill Gwinn Vice-President Clinical Informatics Solutions Optum DIA Session: Next Generation Feasibility:
More informationDisclosure Statement. Epidemiological Data
EVALUATION OF THE MEDICATION UTILIZATION OF COPD PATIENTS AT THE MIAMI VA HEALTHCARE SYSTEM Simone Edgerton, PharmD. PGY 1 Pharmacy Resident Miami VA Healthcare System Miami, Florida Simone.edgerton2@va.gov
More informationCOPD in Korea. Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum
COPD in Korea Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum Mortality Rate 1970-2002, USA JAMA,2005 Global Burden of Disease: COPD WHO & World
More informationCOPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis.
1 Definition of COPD: COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis. Airflow obstruction may be accompanied by airway hyper-responsiveness
More informationCLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease
CLINICAL PATHWAY Acute Medicine Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Table of Contents (tap to jump to page) INTRODUCTION 1 Scope of this Pathway 1 Pathway Contacts
More informationPulmonary Rehabilitation. Palmetto GBA, Jurisdiction 11 MAC Provider Outreach and Education
Pulmonary Rehabilitation Palmetto GBA, Jurisdiction 11 MAC Provider Outreach and Education Pulmonary Rehabilitation Pulmonary Rehabilitation is a multi-disciplinary program of care for patients with chronic
More information11/27/18. Challenges in Pulmonary and Critical Care: Alpha-1 Antitrypsin Deficiency: New Hope for Diagnosis and Treatment. Faculty.
Challenges in Pulmonary and Critical Care: 2018 Alpha-1 Antitrypsin Deficiency: New Hope for Diagnosis and Treatment 1 Faculty Adam Wanner, MD Joseph Weintraub Professor of Medicine Division of Pulmonary
More informationCOPD: Applying New Guidelines to Optimizing Evaluation and Treatment
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationCOPD as a comorbidity of heart failure in elderly patients
COPD as a comorbidity of heart failure in elderly patients Professor Mitja Lainscak, MD, PhD, FESC, FHFA Departments of Cardiology and Research&Education, General Hospital Celje Faculty of Medicine, University
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #51 (NQF 0091): Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
More informationOnline Data Supplement. Prevalence of Chronic Obstructive Pulmonary Disease in Korea: Results of a Population-based Spirometry Survey
Online Data Supplement Prevalence of Chronic Obstructive Pulmonary Disease in Korea: Results of a Population-based Spirometry Survey Dong Soon Kim, MD, Young Sam Kim MD, Kee Suk Chung MD, Jung Hyun Chang
More informationFact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD)
Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD) Jin S. Oh, PharmD Larkin Community Hospital January 10, 2016 Fact COPD is the third leading cause of death in the United
More informationPrince Edward Island Chronic Obstructive Pulmonary Disease (COPD) Trends
Prince Edward Island Chronic Obstructive Pulmonary Disease (COPD) Trends 2001-2011 December 2014 Population Health Assessment and Surveillance Unit, Chief Public Health Office, Department of Health and
More informationCenter for Respiratory and Sleep Medicine COPD Chronic Disease Management Program
Center for Respiratory and Sleep Medicine COPD Chronic Disease Management Program Cristina Ashworth, NP Khalil Diab,MD Center for Respiratory and Sleep Medicine Subgroup of Indiana Internal Medicine Consultants
More informationCystic Fibrosis Panel Applications (Dornase Alfa) Contents
Cystic Fibrosis Panel Applications (Dornase Alfa) Contents Page 2-4: Entry and Stopping Criteria for Treatment with Dornase Alfa Page 5-9: Application and consent forms for a one month trail and long term
More informationBreaking Down Barriers to Pulmonary Therapies: Patient Education, Teach Back, and More
Breaking Down Barriers to Pulmonary Therapies: Patient Education, Teach Back, and More Char Raley, RRT Brandon Johnson, PharmD, BCPS Pulmonary and Critical Care Symposium June 12 th, 2015 We have had no
More information9/22/2015 CONFLICT OF INTEREST OBJECTIVES. Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationUnderstanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationDisclosures. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease May 14, 2016 Orlando, FL COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United States. Alarmingly, COPD recently became
More informationChronic Disease Management Quality Improvement Program: Indicators of Best Practice
Chronic Disease Management Quality Improvement Program: Indicators of Best Practice This document will provide details of the indicators for the four chronic diseases included in CDM-QIP with clarification
More informationHow to treat COPD? What is the mechanism of dyspnea? Smoking cessation
: The Increasing Role of the FP Alan Kaplan, MD, CCFP(EM) Presented at the Primary Care Today: Education Conference and Medical Exposition, Toronto, Ontario, May 2006. Chronic obstructive pulmonary disease
More informationDisclosure and Conflict of Interest 8/15/2017. Pharmacist Objectives. At the conclusion of this program, the pharmacist will be able to:
Digging for GOLD Rebecca Young, PharmD, BCACP, Roosevelt University College of Pharmacy Assistant Professor of Clinical Sciences Practice Site Advocate Medical Group-Nesset Pavilion Disclosure and Conflict
More informationPresented by the California Academy of Family Physicians 2013/California Academy of Family Physicians
Family Medicine and Patient-Centered Asthma Care Presented by the California Academy of Family Physicians Faculty: Hobart Lee, MD Disclosures: Jeffrey Luther, MD, Program Director, Memorial Family Medicine
More informationSession #206, March 8, 2018 Susan J. Kressly, MD, FAAP, Kressly Pediatrics Dr. Jacques Orces, D.O., Nicklaus Children s Hospital
Improving Preventative Care in Pediatrics through Health and Technology: A Davies Story Session #206, March 8, 2018 Susan J. Kressly, MD, FAAP, Kressly Pediatrics Dr. Jacques Orces, D.O., Nicklaus Children
More informationTARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS
TARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS Recommendation PULMONARY FUNCTION TESTING (SPIROMETRY) Conditional: The Expert Panel that spirometry measurements FEV1,
More informationONLINE DATA SUPPLEMENT - ASTHMA INTERVENTION PROGRAM PREVENTS READMISSIONS IN HIGH HEALTHCARE UTILIZERS
R2 (REVISED MANUSCRIPT BLUE 200208-877OC) ONLINE DATA SUPPLEMENT - ASTHMA INTERVENTION PROGRAM PREVENTS READMISSIONS IN HIGH HEALTHCARE UTILIZERS Mario Castro, M.D., M.P.H. Nina A. Zimmermann R.N. Sue
More informationEmerging Challenges in Primary Care: 2017
Emerging Challenges in Primary Care: 2017 The Evolving Landscape of COPD: Strategies to Optimize Care and Improve Outcomes Outcome Report for 7 Cities: Sunovion Pharmaceuticals, Inc. Grant ID: MEDONCC
More informationWhat s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university
What s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university Management stable COPD Relieve symptoms Improve exercise tolerance Improve health status Prevent
More informationAdvancing COPD treatment strategies with evidencebased. 17:15 19:15 Monday 11 September 2017 ERS 2017, Milan, Italy
Advancing COPD treatment strategies with evidencebased approaches 17:15 19:15 Monday 11 September 2017 ERS 2017, Milan, Italy Increasing understanding of COPD and the effect on guideline evolution. GOLD
More informationSABA: VENTOLIN EVOHALER (SALBUTAMOL) SAMA: ATROVENT IPRATROPIUM. Offer LAMA (discontinue SAMA) OR LABA
COPD GUIDELINES DIAGNOSIS >35 years of age Symptoms of cough, breathlessness, sputum, wheeze, Risk factor (SMOKING) Spirometry (post bronchodilator) FEV1/FVC = 0.7 ENCOURAGE PATIENTS TO BRING INHALERS
More informationJAWDA Performance Quarterly KPI Profile (Clinic & Centers) March 2018
JAWDA Performance KPI Profile (Clinic & Centers) March 2018 1 P a g e Introduction: Physician office, clinic, and healthcare centers provide primary care function including health education, prevention,
More informationUp in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018
Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management Colleen Sakon, PharmD BCPS September 27, 2018 Disclosures I have no actual or potential conflicts of interest 2 Objectives Summarize
More informationResearch in Real Life. Real Life Effectiveness of Aclidinium Bromide. Version Date: 26 September 2013
Research in Real Life Real Life Effectiveness of Aclidinium Bromide Version Date: 26 September 2013 Project for Almirall Real-life effectiveness evaluation of the long-acting muscarinic antagonist aclidinium
More informationCOPD: A Renewed Focus. Disclosures
COPD: A Renewed Focus Heath Latham, MD Assistant Professor Division of Pulmonary and Critical Care Medicine Disclosures No Business Interests No Consulting No Speakers Bureau No Off Label Use to Discuss
More informationASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp ASTHMA CARE FOR CHILDREN
More informationChronic obstructive pulmonary disease
0 Chronic obstructive pulmonary disease Implementing NICE guidance June 2010 NICE clinical guideline 101 What this presentation covers Background Scope Key priorities for implementation Discussion Find
More informationPFT Interpretation and Reference Values
PFT Interpretation and Reference Values September 21, 2018 Eric Wong Objectives Understand the components of PFT Interpretation of PFT Clinical Patterns How to choose Reference Values 3 Components Spirometry
More informationUpdate on heterogeneity of COPD, evaluation of COPD severity and exacerbation
Update on heterogeneity of COPD, evaluation of COPD severity and exacerbation Yung-Yang Liu, MD Taipei Veterans General Hospital Aug 29, 2015 G O lobal Initiative for Chronic bstructive L D ung isease
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More informationCrystal Run Healthcare's Journey To NCQA ACO Accreditation
Crystal Run Healthcare's Journey To NCQA ACO Accreditation Scott Hines, MD Co-Chief Clinical Transformation Officer AMGA QI Council Meeting March 13, 2013 NCQA Accreditation What? Voluntary program Assesses
More informationProvider Respiratory Inservice
Provider Respiratory Inservice 2 Welcome Opening Remarks We will cover: Definition of Asthma & COPD Evidence based guidelines for diagnosis, evaluation, and management of asthma Evidence based guidelines
More informationApproved Care Model for Project 3gi: Integration of Palliative Care into the PCMH Model
1 Approved Care Model for Project 3gi: Integration of Palliative Care into the PCMH Model OneCity Health Webinar January 13, 2016 Overview of presentation 2 Approach to care model development Project overview
More informationTHE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable
THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. COPD in the United States Third leading cause
More informationClinical Safety & Effectiveness Cohort # 15
Clinical Safety & Effectiveness Cohort # 15 Spirometry Testing for COPD Patients DATE Educating for Quality Improvement & Patient Safety 1 The Team Division o Sandra Adams, MD, MS: Team Leader o Cynthia
More informationChronic Obstructive Pulmonary Disease Guidelines and updates
Chronic Obstructive Pulmonary Disease Guidelines and updates October 20, 2018 Saratoga Springs, NY COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United
More informationAround-COPD Verona (Italy), January Highlights
Introduction Around-COPD Verona (Italy), January 18 2017 Highlights Prof. Dal Negro chairman of the symposium, opened the congress by highlighting the burden of COPD as a chronic invalidating disease affecting
More informationAsthma COPD Overlap (ACO)
Asthma COPD Overlap (ACO) Dr Thomas Brown Consultant Respiratory Physician Thomas.Brown@porthosp.nhs.uk Dr Hitasha Rupani Consultant Respiratory Physician Hitasha.rupani@porthosp.nhs.uk What is Asthma
More informationCOPD: Current Medical Therapy
COPD: Current Medical Therapy Angela Golden, DNP, FNP-C, FAANP Owner, NP from Home, LLC Outcomes As a result of this activity, learners will be able to: 1. List the appropriate classes of medications for
More informationSCREENING AND PREVENTION
These protocols are designed to implement standard guidelines, based on the best evidence, that provide a consistent clinical experience for AHC II Integrated Clinical Delivery Network patients and allow
More informationINITIATING A COPD CLINIC: PROTOCOL & ASSESSMENT
COPD Resource Pack Section 2A INITIATING A COPD CLINIC: PROTOCOL & ASSESSMENT In this section: 1. Initiating a COPD Clinic 2. Equipment for a COPD Clinic 3. Primary Care Chronic Obstructive Pulmonary Disease
More informationUnderstanding the mode of action of a drug using Functional Respiratory Imaging (FRI) Roflumilast Study. Jan De Backer, MSc, PhD, MBA CEO
Understanding the mode of action of a drug using Functional Respiratory Imaging (FRI) Roflumilast Study Jan De Backer, MSc, PhD, MBA CEO IPAC RS/UF Orlando Inhalation Conference March 20, 2014 OVERVIEW
More informationOffice Based Spirometry
Osteopathic Family Physician (2014)1, 14-18 Scott Klosterman, DO; Woodson Crenshaw, OMS4 Spartanburg Regional Family Medicine Residency Program; Edward Via College of Osteopathic Medicine - Virginia Campus
More informationPCP and Specialist Communication and Collaboration. May 4, 2011
PCP and Specialist Communication and Collaboration May 4, 2011 Lowell General PHO 280 Physicians 200 Specialists 80 PCPs: Pediatricians, Family Practice and Internal Medicine Lowell General Hospital 217
More informationCOPD GOLD Guidelines & Barnet inhaler choices. Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust
COPD GOLD Guidelines & Barnet inhaler choices Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust GOLD 2017 Report: Chapters 1. Definition and Overview 2. Diagnosis and Initial
More informationRoflumilast (Daxas) for chronic obstructive pulmonary disease
Roflumilast (Daxas) for chronic obstructive pulmonary disease August 2009 This technology summary is based on information available at the time of research and a limited literature search. It is not intended
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
DRAFT NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary
More informationChanging Landscapes in COPD New Zealand Respiratory Conference
Changing Landscapes in COPD New Zealand Respiratory Conference Dr Robert Young BMedSc MBChB DPhil (Oxon) FRACP FRCP Associate Professor Consultant Physician Changing Landscapes in COPD: Summary 1. Overview
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary
More informationQuestion by Question (QXQ) Instructions for the Pulmonary Diagnosis Form (PLD)
Question by Question (QXQ) Instructions for the Pulmonary Diagnosis Form (PLD) A Pulmonary Diagnosis Form is filled out by the reviewer for all medical records that are sent to them for review by the CSCC.
More informationReferring for specialist respiratory input. Dr Melissa Heightman Consultant respiratory physician, UCLH,WH, CNWL
Referring for specialist respiratory input Dr Melissa Heightman Consultant respiratory physician, UCLH,WH, CNWL Respiratory Specialist- who? GPSI Community Team Secondary Care Respiratory physician and
More informationSPIROMETRY TECHNIQUE. Jim Reid New Zealand
Jim Reid New Zealand The Basics Jim Reid Spirometry measures airflow and lung volumes, and is the preferred lung function test in COPD. By measuring reversibility of obstruction, it is also diagnostic
More information2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters
GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized
More informationPFT s / 2017 Pulmonary Update. Eric S. Papierniak, DO University of Florida NF/SG VHA
PFT s / 2017 Pulmonary Update Eric S. Papierniak, DO University of Florida NF/SG VHA Outline Overview of pulmonary function testing Uses/indications/limitations Technical aspects Basics of interpretation
More informationReducing lung volume in emphysema Surgical Aspects
Reducing lung volume in emphysema Surgical Aspects Simon Jordan Consultant Thoracic Surgeon Royal Brompton Hospital Thirteenth Cambridge Chest Meeting April 2015 Surgical aspects of LVR Why we should NOT
More informationOptimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center
Optimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center dtaylor@ochsner.org Observations from Yesterday EPIC is epidemic No EMR No Way!!! Accountability/Benchmarking
More informationDana L. Gilbert Chief Operating Officer Sharon Rudnick Vice President Outpatient Care Management
Ambulatory Sensitive Admissions Dana L. Gilbert Chief Operating Officer Sharon Rudnick Vice President Outpatient Care Management 1 Sites Of Care Advocate Health Care 12 Hospitals 10 acute care hospitals
More informationClinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene
Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Emily S. Wan, John E. Hokanson, James R. Murphy, Elizabeth A. Regan, Barry J. Make, David A. Lynch, James D. Crapo, Edwin K.
More informationAlgorithm for the use of inhaled therapies in COPD Version 2 May 2017
Algorithm for the use of inhaled therapies in COPD This document has been revised by the Berkshire West Respiratory Network to support clinicians in selecting the most appropriate, cost effective treatments
More informationSCAPIS. Swedish CArdioPulmonary BioImage Study. SCAPIS outline. one of the largest cardiopulmonary research programs in Sweden
SCAPIS Swedish CArdioPulmonary BioImage Study one of the largest cardiopulmonary research programs in Sweden SCAPIS outline Identification of vulnerable plaques CTA Ultrasound (carotid artery) MRI (carotid
More information